Bristol Myers Squibb · 1 day ago
Data Scientist
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. They are seeking a Data Scientist to support early-stage pharmaceutical programs by managing and harmonizing omics datasets and enabling scientists to access critical patient-derived models.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Compile and harmonize de-identified patient meta-data from multiple internal and external resources (includes clinical treatment history, clinical characteristics, patient demographics, model growth parameters, etc)
Compile and format omics datasets from multiple internal and external resources including RNASeq, DNASeq, Copy Number and scRNASeq datasets
Develop automated scripts to help harmonize datasets from multiple data sources
Load formatted datasets into a proprietary interface to enable access by all client employees
This role may extend to providing some high-level QC assessment of data sets based on a defined set of parameters
Qualification
Required
Strong coding skills in either R (preferred) and/or python. Experience in Java desired but not mandatory
Background in bioinformatics, experience working with RNA-Seq and other NGS data
Bachelors degree in bioinformatics, biology, computer science, or a related field, with 3+ years of hands-on bioinformatics experience after graduation, in industry or academia
Preferred
experience in cancer
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
2026-01-07
2026-01-07
2026-01-07
Company data provided by crunchbase